Paul Michaels
Paul Michaels is a life sciences executive with more than two decades of experience building strategic partnerships and leading transactions between Japan and the United States. He has worked with companies including Celgene Corporation, Sumitomo Pharmaceuticals, Teva Pharmaceuticals and Gilead. During nearly 18 years at Inabata & Co., Ltd., he led transactions that brought pharmaceutical products to the Japanese market.
Michaels co-founded Nobelpharma Co., Ltd. in 2003 and founded Curative Biotech in 2020, where he focuses on capital-efficient therapeutic development and strategic partnerships. Michaels also supports Type 1 diabetes research through his involvement with the Juvenile Diabetes Research Foundation.
Contact info
- Website:
- https://curativebiotech.com/
ArticleWhy inherited retinal disease treatment requires more than gene therapy
Most inherited retinal diseases still have no approved therapy despite advances in gene therapy. This article explores why researchers are targeting shared disease mechanisms alongside individual mutations.